Ceramide-mediated mitochondrial damage in diabetic retinopathy investigated by novel microfluidic O2 sensing and bio-mimetic electrochemistry
Ceramide-mediated mitochondrial damage in diabetic retinopathy investigated by novel microfluidic O2 sensing and bio-mimetic electrochemistry
批准号:
9904655
负责人:
Julia V Busik
金额:
$37.29万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-04-01 至 2022-03-31
关键词:
AddressAffectApoptosisBAX geneBiomimeticsBlindnessCell Membrane PermeabilityCellsCeramidesClinical TrialsComplexComplicationCrista ampullarisCytoplasmDataDiabetes MellitusDiabetic RetinopathyElectrochemistryElectron TransportElectron Transport Complex IIIEndothelial CellsEnzymesEpigenetic ProcessEstrogen receptor positiveEventFluorescenceGenus HippocampusImpairmentInduction of ApoptosisInflammatoryInhibition of ApoptosisInvestigationIschemiaLeadLipidsMeasuresMediatingMetabolismMethodologyMethodsMicrofluidicsMitochondriaMitochondrial DNAModificationNeuronsOuter Mitochondrial MembraneOxidative StressOxygenPathogenesisPathologyPathway interactionsPermeabilityPhagocytesPhysiologyPlayPreventionProductionProteinsReperfusion TherapyRespirationRespiratory ChainRetinaRetinal DiseasesRoleSamplingSphingolipidsSphingomyelinsStrokeStructure of retinal pigment epitheliumSuccinatesSwellingSynapsesTNFRSF10B geneTestingTissuesUp-RegulationVascular Endothelial Growth Factorsacid sphingomyelinaseclinically relevantcytochrome ccytokinediabeticdihydroceramide desaturasedrug developmentmitochondrial dysfunctionmitochondrial fitnessneuron lossnovelnovel strategiesrespiratory enzymesuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Despite recent success in treatment approaches, diabetic retinopathy (DR) remains a
leading cause of progressive vision loss and blindness. Conceptual and technical breakthroughs
to identify novel targets and strategies to cure this complication are paramount. We believe that
such a breakthrough is offered by recent evidence of mitochondrial dysfunction in diabetic
retinopathy in combination with the data from large clinical trials demonstrating a strong
association between lipid abnormalities and DR progression, and the discovery that ceramide
affects mitochondrial function.
Mitochondria play cornerstone role in cellular metabolism and even slight modification of
mitochondrial function can lead to pathology. Indeed, mitochondrial damage precedes
histopathological abnormalities in DR.
Recent studies demonstrate that there is an intricate connection between ceramide and
mitochondrial function. Mitochondria have been shown to contain many sphingolipids including
sphingomyelin and ceramide, as well as enzymes of sphingolipid pathway. Ceramide-induced
restriction of respiratory chain function at the level of complex III, as well as succinate
accumulation has been shown to be a causative factor in ischemia/reperfusion and stroke-
induced tissue damage.
In addition to effects on respiratory enzymes, ceramides were shown to contribute to
mitochondrial outer membrane permeability either through S1P and hexadecenal production
and activation of BAX/BAK, or directly through the formation of protein-permeable ceramide
channels in mitochondrial outer membranes. These channels are shown to play a key role in
the induction of apoptosis through the release of cytochrome c into the cytoplasm. We have
previously demonstrated that activation of acid sphingomyelinase is an important early event in
the pathogenesis of diabetic retinopathy. In this proposal we will test the overall hypothesis
that increased levels of mitochondrial ceramide upon ASM activation leads to a)
cytochrome c release and apoptosis and b) restriction on mitochondrial respiratory chain
function in REC and RPE cells in diabetes. As traditional polarographic or fluorescence
quenching (Seahorse) methods are not conducive for studies on limited amounts of available
retinal tissue and cells, we are developing a novel microfluidic method for functional
mitochondrial studies. We will utilize this novel methodology to assess the role of ASM
activation and ceramide production in mitochondrial damage in diabetic retina.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anti-ceramide immunotherapy for diabetic retinopathy
-
批准号:10440369
-
项目类别:
-
资助金额:$38.02万
-
财政年份:2019
-
负责人:Julia V Busik
-
依托单位:
Anti-ceramide immunotherapy for diabetic retinopathy
-
批准号:10200072
-
项目类别:
-
资助金额:$38.06万
-
财政年份:2019
-
负责人:Julia V Busik
-
依托单位:
Ceramide-mediated mitochondrial damage in diabetic retinopathy investigated by novel microfluidic O2 sensing and bio-mimetic electrochemistry
-
批准号:10132325
-
项目类别:
-
资助金额:$36.12万
-
财政年份:2018
-
负责人:Julia V Busik
-
依托单位:
Cholesterol homeostasis in pathogenesis of DR
-
批准号:10693905
-
项目类别:
-
资助金额:$38.88万
-
财政年份:2015
-
负责人:Julia V Busik
-
依托单位:
Cholesterol homeostasis in pathogenesis of DR
-
批准号:10226319
-
项目类别:
-
资助金额:$37.71万
-
财政年份:2015
-
负责人:Julia V Busik
-
依托单位:
Cholesterol homeostasis in pathogenesis of DR
-
批准号:10542239
-
项目类别:
-
资助金额:$5.05万
-
财政年份:2015
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and Diabetic Retinopathy
-
批准号:10478284
-
项目类别:
-
资助金额:$37.92万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and Diabetic Retinopathy
-
批准号:10659205
-
项目类别:
-
资助金额:$39.09万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and diabetic retinopathy
-
批准号:6984993
-
项目类别:
-
资助金额:$34.83万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and diabetic retinopathy
-
批准号:7271200
-
项目类别:
-
资助金额:$31.81万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and Diabetic Retinopathy
-
批准号:9037380
-
项目类别:
-
资助金额:$38.82万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and Diabetic Retinopathy
-
批准号:8197250
-
项目类别:
-
资助金额:$37.27万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and diabetic retinopathy
-
批准号:7104937
-
项目类别:
-
资助金额:$32.56万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and Diabetic Retinopathy
-
批准号:10297108
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and Diabetic Retinopathy
-
批准号:9188561
-
项目类别:
-
资助金额:$37.44万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and Diabetic Retinopathy
-
批准号:8374409
-
项目类别:
-
资助金额:$35.37万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and Diabetic Retinopathy
-
批准号:8585067
-
项目类别:
-
资助金额:$36.44万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and Diabetic Retinopathy
-
批准号:8041939
-
项目类别:
-
资助金额:$38.6万
-
财政年份:2005
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and retinal endothelial cell dysfunction
-
批准号:6758620
-
项目类别:
-
资助金额:$14.95万
-
财政年份:2003
-
负责人:Julia V Busik
-
依托单位:
Dyslipidemia and retinal endothelial cell dysfunction
-
批准号:6674628
-
项目类别:
-
资助金额:$14.95万
-
财政年份:2003
-
负责人:Julia V Busik
-
依托单位:
海外基金